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Decreased neonatal pain response after
vaginal-operative delivery with Kiwi
OmniCup versus metal ventouse
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Abstract
Background: Vaginal delivery, especially operative assisted vaginal delivery, seems to be a major stressor for the
neonate. The objective of this study was to evaluate the stress response after metal cup versus Kiwi Omnicup®
ventouse delivery.
Methods: The study was a secondary observational analysis of data from a former prospective randomised placebo
controlled multicentre study on the analgesic effect of acetaminophen in neonates after operative vaginal delivery
and took place at three Swiss tertiary hospitals. Healthy pregnant women ≥35 weeks of gestation with an estimated
fetal birth weight above 2000 g were recruited after admission to the labour ward. Pain reaction was analysed by pain
expression score EDIN scale (Échelle Douleur Inconfort Nouveau-Né, neonatal pain and discomfort scale) directly after
delivery. For measurement of the biochemical stress response, salivary cortisol as well as the Bernese Pain Scale of
Newborns (BPSN) were evaluated before and after an acute pain stimulus (the standard heel prick for metabolic testing
(Guthrie test)) at 48–72 h.
Results: Infants born by vaginal operative delivery displayed a lower pain response after plastic cup than metal cup
ventouse delivery (p < 0.001), but the pain response was generally lower than expected and they recovered fully
within 72 h.
Conclusions: Neonatal pain response is slightly reduced after use of Kiwi OmniCup® versus metal cup ventouse.
Trial registration: Trial was registered under under NCT00488540 on 19th June 2007.
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Background
Childbirth and especially the mode of delivery is a major
stressor for the neonate. Approximately 3-20% of all
deliveries worldwide are operative vaginal deliveries with
a shift from forceps to ventouse deliveries during the last
decades [1, 2]. The neonate’s stress and pain response
after different types of delivery are difficult to gauge. In
a previously published study, we showed that neonates
born by assisted vaginal delivery in general had the high-
est burden of pain compared to those delivered by
vaginal birth or caesarean section as reflected by neo-
natal pain scores and saliva cortisol [3]. Pain response
after vacuum extraction was also associated with higher
cord blood cortisol levels [4, 5].
The disposable PalmPump® cup, Kiwi OmniCup®
(Clinical Innovations Inc., Murray, Utah, USA), intro-
duced in obstetric practice in 1999, seems to be compar-
able to the conventional metal cup with regard to safety,
but has a higher failure rate of 30.1% versus 19.2% [6].
The metal cup resulted in a non-significantly higher rate
of substantial head injuries compared to the use of the
Kiwi OmniCup® (38 versus 23%) in one study [7] while
another study showed no differences in scalp injury [8].
To our knowledge, there is no study examining the pain
response after assisted vaginal deliveries using different
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types of ventouse and/or analysing the relation of the in-
fant’s pain response to the neonate’s head trauma. This
study investigates the pain response after metal versus
Kiwi OmniCup® ventouse in an observational analysis of
a former prospective randomised placebo controlled trial
about the analgesic effect of acetaminophen in neonates
after operative vaginal delivery.
Methods
We present a secondary observational data analysis from
a former prospective, randomised, double-blind and
placebo-controlled, national multicentre study on the ef-
fect of paracetamol (acetaminophen) as neonatal pain re-
lief after ventouse deliveries [9]. The study was approved
by each local institutional review board in Basel, Bern
and Zurich. The trial was registered under www.Clinical-
Trials.gov under NCT00488540 on 19th June 2007.
The inclusion criteria were a gestational age of ≥
35 weeks and a birth weight of at least 2000 g. Exclusion
criteria were congenital malformations, administration
of opioids to the mother during the last 24 h before
delivery, and rotational or failed ventouse delivery. All
eligible women were informed about the study during
antenatal visits or after entering the delivery ward and
were enrolled with a written parental informed consent
shortly before or directly after delivery. The obstetric op-
erator, who performed the ventouse delivery, was asked
to fill in a questionnaire about the indication and details
of the delivery mode, including an account of complica-
tions like air suction or “detachment” of the cup from
the neonate’s head and the assessment of neonatal head
injury directly after each delivery.
Participating neonates were randomised to either
treatment with two weight-adapted suppositories of
paracetamol (60, 80, or 100 mg per dose) or placebo at 2
and 8 h after delivery, respectively. All neonates, who
were transferred directly after delivery to the neonatal unit
or left the hospital prior to metabolic testing at day 2 to 3,
were considered drop outs. The current observational
analysis compared pain response after metal cup versus
Kiwi OmniCup® ventouse. Deliveries by forceps or by ven-
touse using a silicone vacuum device were excluded.
Study outcomes included two validated pain scales,
which were assessed at different time points. At first,
prolonged pain and discomfort were measured by the
EDIN scale (Échelle Douleur Inconfort Nouveau-Né,
neonatal pain and discomfort scale) during the first 24 h
of life. This pain scale uses five behavioural indicators of
prolonged pain: facial activity, body movements, quality
of sleep, quality of contact with nurses, and consolability
[10]. Each indicator was scored from 0 to 3 by specially
trained nurses or midwives at 2, 4, 8, 12, and 24 h. An
EDIN score ≥ 5 is considered to indicate significant pain
[11]. The primary endpoint was the pain response by
EDIN score within 24 h as estimated by the EDIN AUC.
Secondly, an acute pain response was then assessed after
the standard heel prick for metabolic testing (Guthrie
test) at day 2 to 3 of life by 7 behavioural indicator of
the Bernese Pain Scale of New-borns (BPSN) with a
score of 0 to 3 for each indicator: alertness, duration of
crying, time to calm, skin colour, eyebrow bulge with eye
squeeze, posture, and breathing pattern [12]. A BPSN of
0–6 represents absence of pain and a score of 9–17
equals a normal response to an acute painful event like
capillary blood sampling. BPSN was obtained by nurses
directly before and after the heel prick and was also
videotaped for scoring by a single reviewer. Correlation
(Spearman rank order coefficient) of BPSN scores be-
tween nurses and reviewer was 0.798 (p < .001) and the
rate of agreement (Cohen kappa) to describe a BPSN ≥ 9
was 0.784 (p < .001). Additionally to the pain expression
scales, salivary cortisol were analysed to measure the
Fig. 1 Included and excluded patients of the secondary analysis
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biochemical neonatal stress and pain response to acute
pain stimulus (heel prick for metabolic testing (Guthrie
test). Saliva samples for cortisol levels were collected
5 min before and 30 min after the heel prick by placing
a swab under the neonate’s tongue for 2 min and were
stored afterwards at −20 °C until analysis at a certified
external laboratory for examination by DELFIA® (time-
resolved fluoromeric endpoint detection; Wallac, Turku,
Finland). Saliva collection was not collected/not available
from the centre in Zurich. For the detailed description
of the cortisol analysis, see the previously published art-
icle by Schuller et al. [3] Additionally, duration of crying
was measured after metabolic testing. BPSN, salivary
cortisol levels, and scream duration were considered sec-
ondary endpoints.
Statistics
Baseline characteristics of neonates, vacuum variables
and outcome/complications are presented stratified for
ventouse and suppository content. Continuous variables
were tested for differences between the four groups
using Wilcoxon signed-rank tests and chi square tests
for categorical variables. P-values were not adjusted for
multiple testing. The primary endpoint was the area
under the curve (AUC) for the EDIN score during the
first 24 h after birth. EDIN AUC was analysed for an as-
sociation with ventouse and suppository and their inter-
action using linear model. Since the original trial was
randomised for suppository and not for type of ventouse,
the comparison of the latter is of observational character
with the risk of confounding. Propensity scores are one
option for counteracting such bias. We used boosted
logistic regression to correct for imbalances in maternal
and birth characteristics and applied to the linear
model, using inverse probability weighting (IPW) [13].
The confounding variables—used as predictors for the
propensity scores—included centre, analgesia, indica-
tion for vaginal operative delivery, operator, gesta-
tional age, gender, and duration of first stage of
labour. With the exception of centre, covariate bal-
ance was significantly improved by propensity score
weighting. Therefore, as a sensitivity analysis, centre
was included in the propensity score model as was
suggested by Heinze & Jüni 2011 [14]. The secondary
endpoints, BPSN, saliva cortisol levels, and duration
of crying, showed overdispersion and were analysed
in a generalised linear model assuming quasi poisson
error distribution. All statistical analyses were performed
Table 1 Baseline characteristics of neonates
Characteristic Plastic cup
“Kiwi”
Metal cup p
Gestational age (wk) 400/7 ± 11/7 395/7 ± 11/7 .37
Sex ratio (male:female) 17:13
(56.7:43.3)
50:40
(55.6:44.4)
1.00
Birth weight (g) 3327 ± 440 3432 ± 408 .34
Length (cm) 49.9 ± 2.0 50.4 ± 1.9 .38
Head circumference (cm) 34.9 ± 1.3 35.1 ± 1.5 .55
Arterial cord pH 7.22 ± 0.06 7.25 ± 0.07 .13
Apgar score 1 min 8 (6–9) 8 (8–9) .17
Apgar score 5 min 9 (8–9) 9 (9–10) .02
Apgar score 10 min 10 (9–10) 10 (9–10) .78
Maternal epidural/spinal
anaesthesia
74 (83.2) 23 (76.7) .6
Continuous variables are presented as mean ± standard deviation (SD), except
for the Apgar scores, for which median and interquartile range (IQR) are shown.
Categorical variables are shown as absolute numbers and percentages
Table 2 Ventouse variables and outcome/complications
Variable Plastic cup
“Kiwi”
Metal cup p
Participating centre
Bern 15 (50) 4 (4.4) <.001
Basel 15 (50) 51 (56.7)
Zurich 0 (0) 35 (38.9)
Duration of first stage of labour (h) 5.2 (3.7–7.9) 5.1 (3.8–7.5) .96
Duration of second stage of labour (h) 1.5 (0.9–2.4) 2.1 (1.1–2.8) .12
Causes for vaginal assisted delivery
failure to progress in labour 10 (34.5) 43 (47.8) .33
fetal distress 17 (58.6) 43 (47.8)
maternal exhaustion 2 (6.9) 2 (2.2)
others 0 (0) 2 (2.2)
Number of tractions
1 5 (16.7) 10 (11.1) .6
2 12 (40) 50 (55.6)
3 12 (40) 27 (30)
4 1 (3.3) 2 (2.2)
5 0 (0) 1 (1.1)
Complications
none 28 (93.3) 77 (85.6) .01
air aspiration 0 (0) 9 (10)
cup “detachment” 2 (6.7) 0 (0)
no information 0 (0) 4 (4.4)
Severe head injuries
- skin abrasions/lacerations 1 (3.3) 2 (2.2) .51
- cephalhaematoma 1 (3.3) 10 (11.1)
- intracranial haemorrhage 0 (0) 0 (0)
- skull fracture 0 (0) 0 (0)
Study treatment
- paracetamol 18 (60) 43 (47.8) .34
- placebo 12 (40) 47 (52.2)
Categorical variables are shown as absolute numbers and percentages.
Durations of first and second stage of labour are reported with median and
interquartile range (IQR)
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with the statistical software R version 3.1.0 [15]. A level of
significance of α = 0.05 was used.
Results
A total of 140 neonates were recruited in the primary
study. Eight neonates dropped out because of transfer to
the neonatal unit and nine neonates left the hospital
prior to metabolic testing. Of the remaining 123 infants,
we excluded those delivered by a silicone ventouse (n =
2) and one delivered by forceps. Finally, 120 neonates
were included in the analysis set, 30 of which were deliv-
ered by a rigid plastic cup (Kiwi Omnicup®, Clinical In-
novations Inc., Murray, Utah, USA) and 90 by a metal
cup ventouse (Menox AB, Göteborg, Sweden) (Fig. 1).
The baseline characteristics of both groups are shown in
Table 1. Infants who were delivered by plastic cup did
not differ from infants delivered by metal cup ventouse
in respect to gestational age, birth weight, length or head
circumference, epidural or spinal analgesia, or arterial
umbilical cord pH. Only Apgar scores after 5 min were
significantly lower after plastic ventouse. The vacuum
variables are expressed in Table 2. Data of moulding, oc-
ciput position, or pelvic station (head station relating to
the level of maternal ischial spines) were missing. The
choice of ventouse strongly differed between the partici-
pating centres. Zurich and Basel performed more
ventouse deliveries using the metal cup (35/35 and 51/
66, respectively). Bern preferred the KiwiOmni® cup (15/
19). There were no significant differences in indication
for vaginal operative deliveries and traction counts. Air
was aspirated in 10% of the metal cup ventouse. The
cup detached from the neonates’ heads in two cases
using the plastic cup (6.7%) and there was no detach-
ment in the metal cup group. The metal cup provoked
more substantial scalp traumas (cephalhaematoma and
skin abrasions/lacerations) in 13.2% (12/90) compared to
the plastic cup in 6.6% (2/30), but this finding was not
significant (p = 0.51). There was no case of subgaleal or
intracranial haemorrhage and skull fracture.
The results based on IPW showed a reduction in
EDIN AUC by plastic versus metal cup of −23.82 (CI:
−36.2 and −11.4, p < 0.001; analysis without IPW p =
0.02). At each time, there was a tendency of higher
EDIN scores after metal cup use with a maximum at
two hours after birth (Fig. 2). The EDIN score declined
within the next two hours and reached lower values four
hours after birth, which was not significantly different in
both groups. There was no effect of the suppository on
EDIN AUC (p = 0.8; analysis without IPW p = 0.77) and
no interaction of suppository and instrument was found
(p = 0.63; analysis without IPW p = 0.61) (Fig. 3). How-
ever, the proportion of neonates with high pain scores
Fig. 2 Pain intensity measured by EDIN score at different time points after metal versus plastic ventouse deliveries. The boxes show the interquartile
range with the median represented by a horizontal line. Whiskers correspond to 1.5 interquartile ranges
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(EDIN ≥ 5) was not statistically significantly different at
any time (Table 3). The proportion of EDIN ≥ 5 was
higher in the metal/placebo versus plastic/placebo
group, but the difference was not statistically significant.
The effect of maternal analgesia on EDIN score could
not be tested because of the high proportion of mothers
with epidural/spinal anaesthesia (n = 97) versus busco-
pan only (n = 13), other analgesics (n = 4), and no anal-
gesia at all (n = 4). There was no statistically significant
effect of light or severe head trauma on EDIN AUC
(p = 0.51 and p = 0.63, respectively).
Salivary cortisol levels could only be measured in
58 out of 85 neonates before and 52 out of 85 neo-
nates after Guthrie testing, respectively, due to insuf-
ficient saliva volume for analysis. The evaluation
based on IPW showed no significant differences be-
tween metal and plastic cup in BPSN before (p = 0.86)
and after heel prick (p = 0.22), salivary cortisol levels
before (p = 0.56) and after heel prick (p = 0.93), or
duration of crying after heel prick for metabolic test-
ing at day 2 to 3 (p = 0.1), irrespective of the
suppository content. The neonates, who received a
paracetamol suppository, showed a longer duration of
crying, higher cortisol levels, and increased BPSN
scores after heel prick in both groups, but these dif-
ferences were not significant (Table 3).
Discussion
To our knowledge, this is the first study on neonatal
pain response after metal versus Kiwi OmniCup® ven-
touse deliveries. Neonates delivered by Kiwi OmniCup®
ventouse presented a significantly lower pain response in
the first 24 h estimated in the EDIN AUC than those de-
livered by plastic cup ventouse (p < 0.001). There were
no significantly different EDIN scores ≥ 5, reporting sub-
stantial pain at each time point, but the proportion of
EDIN ≥ 5 was higher in the metal/placebo versus plastic/
placebo group. This observation was not statistically sig-
nificant, which might be due to lack of power in both
placebo groups.
In alignment to the findings by Attilakos et al. [7], we
observed a non-significantly higher rate of substantial
head injuries after metal versus plastic cup ventouse.
Mola et al. [8] found no differences in head trauma be-
tween Kiwi OmniCup® and Bird metal cup at all. We
found no significant association between substantial or
any head injuries and higher EDIN scores. This finding
suggests that the reported higher pain response after
ventouse delivery might be due to the traction force it-
self rather than the resulting head trauma. Although an
even higher traction level resulting e.g. from head pres-
entation, head station [16] and/or type of device might
lead to an increased risk of substantial head injury. In
Fig. 3 Pain intensity within first 24 h after metal versus plastic ventouse delivery, measured by the area under the curve (AUC) of the EDIN score according
to suppository. The boxes show the interquartile range with the median represented by a horizontal line. Whiskers correspond to 1.5 interquartile ranges
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one study by Vacca, the traction force reached up to
11.5 kg (113N =Newton) in 79.8% of successful
ventouse deliveries in nulliparous women after Kiwi
OmniCup® [17]. In only two cases (1.7%) exceeded the
traction force more than 13.5 kg (132 N). In a recently
published study [18], the average peak traction force
after using the Bird metal cup reached 225 N, which cor-
responded to a mass equivalent of 23 kg. The traction
force after Bird metal cup seems to be substantially
higher than those after Kiwi OmniCup® extraction, but a
higher proportion of low-cavity and outlet ventouse was
included in the study by Vacca [17] compared to the
study by Petterson et al. [18]. In a small study from 1979
[19], 216 N (corresponding to a mass of 22 kg) was sug-
gested to be a safe traction force limit for using the
50 mm Malmstrom metal cup. No sensor calculating the
traction force was used in our study.
The plastic and the metal cup groups had declining
EDIN scores within four hours after delivery reaching
steady low scores afterwards. The elevated salivary corti-
sol levels reported in our previously published study
stated that the mode of vaginal operative delivery is
the most stressful way of delivery for the infant com-
pared to spontaneous delivery and caesarean section
[3]. Although stressful, there might be a regulating
analgesic effect by vasopressin during spontaneous
and assisted vaginal delivery compared to elective cae-
sarean section [20–24]. Studies comparing the vaso-
pressin levels after vaginal operative delivery and
spontaneous delivery are lacking. Interestingly, studies
on the stress response (salivary cortisol and duration
of crying) after routine vaccination even two months
after delivery show an increase in pain response in
those infants who had elevated cortisol levels directly
after delivery, but the two-month response did not
differ by mode of delivery [5]. This suggests that
stress at birth could alter the stress regulatory system
in the neonate by programming the hypothalamic-
pituitary-adrenal axis affecting the pain response at
two months of age and might even alter the stress re-
sponse in later life. This theory however needs to be
further elucidated.
Table 3 Median and IQR of prolonged pain (EDIN) after delivery, acute pain (BPSN) before/after heel prick at day 2 to 3 of life, and
duration of crying after heel prick (p-values test difference between all groups)
Variable Plastic cup
“Kiwi”
Metal cup P
Placebo Paracetamol Placebo Paracetamol
EDIN AUC 24 (15–34) 29 (2–50) 43 (20–72) 48 (32–66) .02
EDIN (median, IQR)
2 h 2 (1–3) 2 (1–5) 3 (0–5) 3 (2–5) .34
4 h 1 (0–1) 1 (0–4) 1 (0–2) 1 (0–2) .55
8 h 1 (0–1) 1 (0–2) 2 (0–4) 2 (1–3) <.00
12 h 1 (0–2) 1 (0–2) 2 (0–4) 2 (1–4) .28
24 h 0 (0–1) 1 (0–3) 2 (0–4) 2 (1–4) .03
EDIN≥ 5 (%)
2 h 11.1 34.6 28 28.2 .37
4 h 5.6 15.4 15.9 12.7 .69
8 h 11.1 0 19.5 14.1 .1
12 h 0 7.7 3.7 9.9 .27
24 h 0 7.7 19.5 18.3 .12
BPSN (nurses)
before heel prick 0 (0–2) 0 (0–1) 0 (0–1) 0 (0–2) .66
after heel prick 3 (0–7) 5 (4–9) 3 (1–5) 4 (2–7) .07
BPSN (reviewer)
before heel prick 0 (0–0) 0 (0–1) 0 (0–1) 0 (0–1) .7
after heel prick 3 (2–9) 5 (3–7) 3 (2–6) 5 (3–8) .43
Salivary cortisol levels (nmol/L)
- before heel prick (n = 58) 6.1 (3.7–8.4) 5.1 (4.4–6.8) 3.9 (2.3–7.7) 4.1 (2.5–5.9) .56
- after heel prick (n = 52) 13.2 (8.6–16) 18.9 (4.5–24.2) 8.1 (4.5–25.4) 10.5 (6.6–17.3) .93
Duration of crying (sec) 3 (0–86) 22 (0–61) 0 (0–23) 16 (0–61) .27
Huhn et al. BMC Pregnancy and Childbirth  (2017) 17:47 Page 6 of 8
There are several limitations to our study. Since the
aim of the original trial was not to investigate the effect
of different types of ventouse on pain in neonates this
comparison is of observational character and groups dif-
fer in size. Propensity score methods are currently the
best option to reduce potential bias between non-
randomised groups, and are superior to “naïve” observa-
tional data analysis. However, results have to be
interpreted by keeping in mind that potential bias can
only be so far reduced as all relevant confounders, i.e.
those variables that influence the outcome of interest,
are measured. The propensity score weighting was ad-
justed for the baseline imbalance of the variable centre.
Other aspects of practice associated with the preference
of the centres for a type of ventouse cup like e.g. experi-
ence with the handling of the device could additionally
have influenced the results in a not sufficiently acknowl-
edged manner. The strengths of our study are its pro-
spective design, the concomitant use of pain scores and
the cortisol measurements. Despite its limitations, our
study is the first to investigate the influence of type of
ventouse on the neonatal pain response. Our results in-
dicate that neonates delivered by Kiwi OmniCup® ven-
touse present a slightly reduced pain response within the
first 24 h. As this observation might influence further
clinical management, it should be interpreted with cau-
tion and merits further investigation by a randomised
controlled trial.
Conclusion
In summary, we conclude that infants born by vaginal op-
erative delivery present a slightly reduced pain response
after plastic cup versus metal cup ventouse delivery, but
the pain response is generally lower than expected and
normalises in both ventouse groups within 72 h.
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